In this large nationwide cohort study of 10 689 US veterans with incident IBD, we found that incident use of TNF inhibitors was independently associated with higher risk of progressive kidney function decline but was not associated with risk of all-cause mortality. This evidence concerns the gene TNF and inflammatory bowel disease.